Latest filing published 26 Feb 2021 for Acura Pharmaceuticals, INC, €2,485.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -33.8%Entry US$6.00 · Close at T+365 US$3.97
- -54.0%Entry US$16.30 · Close at T+365 US$7.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James F. Emigh: trading record in brief
James F. Emigh appears in our data through filings on Acura Pharmaceuticals, Inc shares, published by SEC (Form 4). We count 21 filings; the first trade dates from 24 April 2009 and the latest from 24 February 2021.
The open-market record is one-sided, with 9 purchases worth €56k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 8 option exercises.
Half of the purchases are above €1,325 and half below. After 8 purchases with a full 90-day history, the hit rate stands at 88% and the median 90-day move at +28.2%. These figures describe past trades and do not predict future prices.
The latest filing, published on 26 February 2021, reports an option exercise of €2,485 in Acura Pharmaceuticals, Inc. The clock since the last published purchase (18 December 2017) now reads 3,247 days. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James F. Emigh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$0.151Common StockSEC:0001104659-21-029185:0
- 24,667 sharesCommon StockSEC:0001104659-21-001502:0
- 7,402 shares@ US$0.2134.2% of flowCommon StockSEC:0001104659-21-001502:1
- 4,667 sharesCommon StockSEC:0001104659-20-001563:0
- 400,000 shares@ US$0.10Common StockSEC:0001209191-17-066075:0Canonical exit: 14 Mar 2018 (T+90)
- 15,000 shares@ US$1.21Common StockSEC:0001209191-14-034854:0Canonical exit: 14 Aug 2014 (T+90)
- 6,225 shares@ US$1.30Common StockSEC:0001209191-14-005084:0
- 6,225 shares@ US$1.30Common StockSEC:0001209191-13-024112:0
- 6,596 shares@ US$2.22Common StockSEC:0001209191-13-001270:0
- 6,225 shares@ US$1.30Common StockSEC:0001209191-12-006202:0
- 100 shares@ US$2.56Common StockSEC:0001209191-11-044215:0Canonical exit: 10 Nov 2011 (T+90)
- 986 shares@ US$2.58Common StockSEC:0001209191-11-044215:1Canonical exit: 10 Nov 2011 (T+90)
- 300 shares@ US$2.59Common StockSEC:0001209191-11-044215:2Canonical exit: 10 Nov 2011 (T+90)
- 2,200 shares@ US$2.60Common StockSEC:0001209191-11-044215:3Canonical exit: 10 Nov 2011 (T+90)
- 300 shares@ US$2.61Common StockSEC:0001209191-11-044215:4Canonical exit: 10 Nov 2011 (T+90)
- 400 shares@ US$2.62Common StockSEC:0001209191-11-044215:5Canonical exit: 10 Nov 2011 (T+90)
- 714 shares@ US$2.64Common StockSEC:0001209191-11-044215:6Canonical exit: 10 Nov 2011 (T+90)
- 6,225 shares@ US$1.30Common StockSEC:0001209191-11-004679:0
- 18,000 sharesCommon StockSEC:0001209191-09-022764:0
19 of 19 declarations
